ABIGAIL STECK: Open Payments
NPI 1467943944 · SEGUIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 17 payments from 11 companies in 2025. Trend: 2023 $644 · 2024 $305 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $69 |
| Lilly USA, LLC | 3 | $57 |
| PFIZER INC. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: MOUNJARO, VRAYLAR, NURTEC ODT, SHINGRIX, Kerendia, LEQEMBI, Cologuard Collection Kit, QULIPTA.
Industry payments across TX — which companies pay providers there.
